Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-24 @ 10:22 PM
NCT ID:
NCT05329935
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients diagnosed with Congenital Athymia:
* Who are scheduled for implantation with RETHYMIC within the next 30 days, or who were treated with RETHYMIC within the previous 60 days.
* Who have provided written informed consent directly, or written informed consent has been provided by the patient, the parent, or legal guardian.
Exclusion Criteria:
* Written informed consent cannot be obtained.
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
21 Years
Study:
NCT05329935
Study Brief:
Protocol Section:
NCT05329935